Newsbenzinga
Johnson & Johnson Q3 Sets 'Negative Tone For Broader Pharma Sector': Analysts
· Published
Article summary
Johnson & Johnson posted upbeat Q3 results; analysts stayed bullish, though RBC cut its target and noted mixed product and MedTech trends.
An excerpt from the original article.
Comments —
Loading comments…